What's happening
This bill establishes designated sickle cell care centers and outpatient treatment centers in New York and provides related funding and opioid prescription exemptions for sickle cell disease patients.
Why it matters
Creates a network of specialized centers. By designating five hospitals or hospices as "Centers for Sickle Cell Care Excellence" and ten hospitals as outpatient treatment centers, the bill aims to improve access to expert, coordinated care for individuals living with sickle cell disease across New York.
Directs targeted funding to research and care. Each center for excellence will receive $200,000 annually for research, while each outpatient center gets $100,000 per year for operational support—potentially leading to advances in treatment and better facility resources.
Promotes collaboration with academic and research institutions. Mandating formal partnerships with major universities and research institutes, the bill is intended to foster innovation, share expertise, and support workforce development in sickle cell care.
Addresses opioid access for pain management. By exempting sickle cell disease patients from certain opioid prescription restrictions, the bill recognizes the unique, chronic pain associated with the condition and seeks to ensure that patients aren't denied necessary pain relief.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Fund Sickle Cell Treatment Centers
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to ways and means
- Reported referred to ways and means
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Fund Sickle Cell Treatment Centers
In Senate Committee · Finance · Sponsor James Sanders Jr.
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6431
2021-2022 Regular Sessions
IN ASSEMBLY
March 17, 2021
Introduced by M. of A. HYNDMAN -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to establishing the "Sickle Cell Treatment Act"; and making an appropriation therefor
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. This act shall be known and may be cited as the "Sickle Cell Treatment Act".
§ 2. The public health law is amended by adding a new section 2807-aa to read as follows:
§ 2807-aa. Sickle cell centers for excellence and outpatient treatment centers. 1. Centers for sickle cell care excellence. The commissioner shall designate five general hospitals or hospices under article forty of this chapter, upon successful application, as centers for sickle cell care excellence. The designations shall be made through an application designed by the department, and based on service, staffing and other criteria as developed by the commissioner. The centers of excellence shall provide specialized sickle cell disease care, treatment, palliative care, education and related services and shall conduct specialized research into the care, treatment and management of sickle cell disease. Designation as a center for sickle cell care excellence shall not entitle a center to enhanced reimbursement, but may be utilized in outreach and other promotional activities. Each center for sickle cell care excellence shall affiliate and cooperate with major centers of higher learning, including medical colleges, and life science research institutes in the state. The state university shall enter into appropriate legal agreements to enable this cooperation. Each center for sickle cell care excellence shall receive two hundred thousand dollars per year from the department, from amounts appropriated for that purpose, to be used on sickle cell disease research.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08525-01-1
A. 6431 2
2. Outpatient treatment centers. The commissioner shall designate ten hospitals, distributed based on sickle cell patient population concentrations, as sickle cell outpatient treatment centers which shall provide patients treatment for sickle cell disease as an outpatient. Each sickle cell outpatient treatment center shall receive one hundred thousand dollars per year from the department, from amounts appropriated for that purpose, to be used to ensure the proper management and equipping of the centers to care for sickle cell patients.
§ 3. Subdivision 8 of section 3331 of the public health law, as added by section 7-a of part D of chapter 57 of the laws of 2018, is amended to read as follows:
8. No opioids shall be prescribed to a patient initiating or being maintained on opioid treatment for pain which has lasted more than three months or past the time of normal tissue healing, unless the medical record contains a written treatment plan that follows generally accepted national professional or governmental guidelines. The requirements of this paragraph shall not apply in the case of patients who are being treated for cancer or sickle cell disease that is not in remission, who are in hospice or other end-of-life care, or whose pain is being treated as part of palliative care practices.
§ 4. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.